Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

作者： Joshua Choi1, Courtney E. Meilleur1, S.M. Mansour Haeryfar1,2,3,4 1Department of Microbiology and Immunology,Western University, 2Department of Medicine, Division of Clinical Immunology and Allergy,Western University, 3Department of Surgery, Division of General Surgery,Western University, 4Lawson Health Research Institute

简介：

Overview

This article presents a flow cytometry-based in vivo killing assay that assesses cytotoxic T lymphocyte (CTL) responses to tumor antigens. The assay allows for simultaneous quantification of T-cell-mediated cytotoxicity against distinct peptide epitopes, providing insights into immunodominance.

Key Study Components

Area of Science

• Immunology
• Cancer Research
• Flow Cytometry

Background

• The assay measures T-cell cytotoxic function within the intact architecture of secondary lymphoid organs.
• It accurately reflects the absolute number of T-cells rather than just their frequencies.
• Understanding CTL responses is crucial for vaccine and immunotherapeutic design.
• The protocol is specifically tailored to study CD8 T cell responses.

Purpose of Study

• To examine cytotoxic T cell responses to immunodominant and sub-dominant tumor antigens.
• To provide a reliable method for drug efficacy testing.
• To enhance the understanding of CTL dynamics in cancer immunology.

Methods Used

• Flow cytometry for quantifying T-cell-mediated cytotoxicity.
• In vivo assays to maintain the physiological context of T-cell responses.
• Simultaneous assessment of responses to multiple peptide epitopes.
• Analysis of CD8 T cell responses to model tumor antigens.

Main Results

• The assay provides a clear assessment of T-cell cytotoxicity against tumor antigens.
• It reveals the dynamics of CTL responses in a relevant biological context.
• Data supports the design of effective vaccines and immunotherapeutic strategies.
• Demonstrates the importance of absolute T-cell counts in evaluating immune responses.

Conclusions

• The flow cytometry-based assay is a valuable tool for studying CTL responses.
• It offers insights into immunodominance that can inform cancer treatment strategies.
• This method enhances the understanding of T-cell behavior in vivo.

Frequently Asked Questions